China Pharma Holdings, Inc. CPHI

Full chart Compare
Set alert

Price alert · CPHI

All alert types
0.61 USD 0.00 (+0.48%)

At closeNov 4, 2026, 7:32 AM EST

0.61 0.00 -0.51%

Pre-market · Nov 4, 7:32 AM ET

0.584 Day range 0.6354
0.38 52-week range 19.19
YTD
-49.65%
1 year
-60.70%

Revenue & Expenses

Other Operating Income → Expenses: $151.56KExpenses → Gross Loss: $131.95KExpenses → Selling, General & Admin: $2.83MExpenses → Research & Development: $280.90KExpenses → Other Expenses: $99.02KNet Loss → Expenses: $3.19MRevenue → Cost of Revenue: $4.14MOther Operating Income$151.56KNet Loss$3.19MCost of Revenue$4.28MExpenses$3.34MGross Loss$131.95KSelling, General & Admin$2.83MResearch & Development$280.90KOther Expenses$99.02KRevenue$4.14M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CPHI annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
4.14M4.53M7.01M8.10M9.64M
-131.95K-1.99M-281.08K-493.92K349.27K
-3.24M-4.59M-2.75M-3.55M-2.86M
-3.19M-4.74M-3.08M-3.97M-3.40M
-0.74-2.71-9.10-37.80-37.00
CPHI annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
345.11K626.88K1.42M2.03M4.86M
31.00M14.89M16.47M17.78M22.65M
8.26M7.14M9.01M13.49M16.63M
3.60M3.59M4.63M8.76M12.49M
22.74M7.75M7.45M4.29M6.02M
CPHI annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
148.26K-406.06K-699.69K-409.55K-249.84K
-137.25K-291.72K-11.52K-401.96K-438.06K
-294.03K-33.78K73.14K-1.77M4.60M
-59.32K-38.41K-11.52K-401.96K-438.06K
-281.77K-796.96K-606.13K-2.83M3.90M